TGF-ß, which has been studied for more than 30 years, has many jobs. One of them is helping to regulate the immune system. The immunotherapy drugs called checkpoint inhibitors have transformed ...
TGF-beta may be an “old story” in the study of cancer, but a plot twist was recently encountered by scientists from the Medical University of South Carolina. TGF-beta, which is hijacked by cancer ...
Phase 1/2a clinical trial of BI-1206, an anti-CD32b (FcγRIIB) antibody, in combination with pembrolizumab in subjects with advanced solid tumors previously treated with anti-PD-1/PD-L1. This is an ...
IO Biotech presents preclinical data supporting dual-antigen and TGF-β-targeted vaccines for enhancing anti-tumor immunity at AACR 2025. IO Biotech presented new preclinical data at the AACR Annual ...
A new study led by Baylor College of Medicine identifies an underlying mechanism of pathogenesis for osteogenesis imperfecta (OI) in human bone. The report, published in the Journal of Clinical ...
Recent research results from the TGF-beta and cancer research group at the Bellvitge Biomedical Research Institute (IDIBELL), within IT-Liver, a collaborative European action among several research ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results